Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 1, 2007, Pages 37-43

  Quan, Dong Qin ^a   Xu, Gui Xia ^a   Wu, Xiang Gen ^b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Emulsion; Formulation; Puerarin; Self emulsifying; Surfactant

Indexed keywords

OLEIC ACID; POLYSORBATE 80; PROPYLENE GLYCOL; PUERARIN; SURFACTANT;

AREA UNDER THE CURVE; ARTICLE; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; EMULSION; LASER DIFFRACTION; PARTICLE SIZE; SELF EMULSIFYING DRUG DELIVERY SYSTEM;

ANIMALS; BIOLOGICAL AVAILABILITY; DOGS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; ISOFLAVONES; MALE; SOLUBILITY; SOLVENTS; VASODILATOR AGENTS;

EID: 33847642532     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Robinson, J. R. Introduction: Semi-solid formulations for oral drug delivery. Bulletin Technique Gattefosse 1996, 89, 11-13.
2. Aungst, B. J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 1993, 82 (10), 979-987.
3. Gershanik, T.; Benita, S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 2000, 50, 179-188.
4. Khoo, S. M.; Humberstone, A. J.; Charman, W. N. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 1998, 167, 155-164.
5. Kim, J. Y.; Ku, Y. S. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int. J. Pharm. 2000, 194, 81-89.
6. Kommuru, T. R.; Gurley, B.; Kahn, M. A.; Reddy, I. K. et al., Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212 (2), 233-246.
7. Nazzal, S.; Smalyukh, II and Khan, M. A. et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 2002, 20, 235 (1-2), 247-65.
8. Gursoy, R. N.; Benita, S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 2004, April, 58 (3), 173-182.
9. Craig, D. Q. M. The use of self-emulsifying systems as a means of improving drug delivery. Bulletin Technique-Gattefosse. 1993, 86, 21-31.
10. Zhang, Z. R.; You X. J.; He, Q. et al., Determination of Puerarin in plasma by HPLC. J. Chin. Pharm. 1997, 32 (2), 104-106.
11. Craig, D. Q. M.; Barker, S. A.; Banning D.; Booth S. W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 1995, 114, 103-10.
12. Kommuru, T. R.; Gurley, B.; Khan, M. A.; Reddy, I. K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212, 233-46.
13. Pouton, C. W. Formulation of self-emulsifying drug delivery systems. Adv. Drug. Del Rev. 1997, 25, 47-58.
14. Gao, P.; Witt, M. J.; Haskell, R. J.; Shifflett, J. R. et al. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm. Dev. Technol. 2004, 9 (3), 301-9.
15. Poelma, F. G.; Breas, R. and Tukker, J. J. Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat. Pharm. Res. 1990, 7 (4), 392-7.
16. Chiu, Y. Y.; Higaki, K. and Amidon, G. L. et al. Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells. Pharm. Res. 2003, 20 (5), 749-56.